Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-12-01 | Amended | $48,099,985 | $23,949,991 | Equity Only | 06b | SEC link |
| 2024-11-29 | New | $24,149,994 | $24,149,994 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Michael Aberman | Director |
| Milenko Cicmil | Director, Executive |
| David Fallace | Director |
| Drew King | Executive |
| Seth Lieblich | Director |
| Praveen Tipirneni | Director |
| Xu Wu | Director |